Cross-Chirality Generalization by Axial Vectors for Hetero-Chiral Protein-Peptide Interaction Design
arXiv:2602.20176v2 Announce Type: replace-cross Abstract: D-peptide binders targeting L-proteins have promising therapeutic potential. Despite rapid advances in machine learning-based target-conditioned peptide design, generating D-peptide binders remains largely unexplored. In this work, we show that by injecting axial features to $E(3)$-equivariant (polar) vector features, it is feasible to achieve cross-chirality generalization from homo-chiral (L--L) training data to hetero-chiral (D--L) design tasks. By implementing this method within a latent diffusion model, we achieved D-peptide binder
Advances in machine learning, particularly in equivariant neural networks, are enabling new breakthroughs in biochemical design that were previously intractable, evidenced by this new arXiv paper.
This research demonstrates a crucial step towards designing novel therapeutic molecules with improved properties and reduced immunogenicity by leveraging previously underexplored D-peptide binders.
The ability to generalize AI models across different chiralities significantly expands the design space for protein-peptide interactions, accelerating drug discovery and synthetic biology applications.
- · Biopharmaceutical industry
- · Machine learning researchers
- · Patients with untreatable diseases
- · Synthetic biology companies
- · Traditional drug discovery methods
Increased efficiency and success rates in the design of peptide-based therapeutics.
New classes of drugs targeting previously undruggable protein interactions become feasible.
The development of highly stable and selective D-peptide biologics leads to a paradigm shift in precision medicine and personalized therapies.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG